Strategic actions to advance multipurpose prevention technologies in low- and middle-income countries
Open Access
- 3 July 2023
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Reproductive Health
- Vol. 5, 1150857
Abstract
Background: HIV, other sexually transmitted infections (STIs) and unintended pregnancies are critical and interlinked health risks for millions of women of reproductive age worldwide. Multipurpose prevention technologies (MPTs) offer an innovative approach for expanding combined pregnancy and/or disease prevention. So far, MPT development efforts have focused mostly on HIV prevention, but about half of product candidates comprise compounds active against non-HIV STIs as well. This review aims to provide a framework that promotes the efficient advancement of the most promising preclinical products through the development pathway and into the hands of end-users, with a focus on women in low- and middle-income countries (L/MICs).Methods: This mini review provides a summary of the current landscape of the MPT field. It comprises a landscape assessment of MPTs in development, complemented by a series of 28 in-depth, semi-structured key informant interviews (KIIs) with experts representing different L/MIC perspectives.Main results: We identified six primary action strategies to advance MPTs for L/MICs, including identification of key research gaps and priorities. For each action strategy, progress to date and key recommendations are included.Conclusions: To realize the life-saving potential of MPTs and maximize the momentum made to date, a strategic, collaborative and well-funded response to the gaps and next steps outlined in this paper is critical. A coordinated response can add rigor and efficiency to the development process, to successfully advance the most promising MPT products to the hands of end-users.Keywords
This publication has 25 references indexed in Scilit:
- “We are not the same”: African women’s view of multipurpose prevention products in the TRIO clinical studyInternational Journal of Women's Health, 2019
- Surviving in the Valley of Death: Opportunities and Challenges in Translating Academic Drug DiscoveriesAnnual Review of Pharmacology and Toxicology, 2019
- Rhodanine derivatives as potent anti-HIV and anti-HSV microbicidesPLOS ONE, 2018
- The Tablets, Ring, Injections as Options (TRIO) study: what young African women chose and used for future HIV and pregnancy preventionJournal of the International AIDS Society, 2018
- Perfect-use and typical-use Pearl Index of a contraceptive mobile appContraception, 2017
- Multipurpose tenofovir disoproxil fumarate electrospun fibers for the prevention of HIV-1 and HSV-2 infections in vitroInternational Journal of Pharmaceutics, 2017
- Favoring “Peace of Mind”: A Qualitative Study of African Women's HIV Prevention Product Formulation Preferences from the MTN-020/ASPIRE TrialAIDS Patient Care and STDs, 2017
- Global Estimates of the Prevalence and Incidence of Four Curable Sexually Transmitted Infections in 2012 Based on Systematic Review and Global ReportingPLOS ONE, 2015
- The Contraceptive CHOICE Project Round UpClinical Obstetrics and Gynecology, 2014
- Fertility Reduction and the Quality of Family Planning ServicesStudies in Family Planning, 1989